Monoclonal Antibodies Market is estimated to grow at a CAGR of 8.6% during the forecast period. An increasing number of trials for monoclonal antibodies for COVID-19 patients. For instance, in October 2020, Celltrion Group declared the introduction of its Phase III clinical trial investigating CT-P59. It is an anti-COVID-19 monoclonal antibody therapy candidate. The company estimates the enrolment of nearly 1,000 patients to assess population-based prophylaxis in contacts of SARS-CoV-2 infected patients. The prophylaxis post-exposure clinical trial will assess the safety and preventive effect of CT-P59 and whether CT-P59 can produce a counteracting antibody response for the prevention of virus from infecting human cells.
Further, in August 2020, the National Institutes of Health (NIH) introduced a clinical trial that aims to test antibody therapy in hospitalized COVID-19 patients. Under the trial, COVID-19 patients at selected hospitals can volunteer in a clinical trial intended to test the efficacy and safety of an effective novel treatment for COVID-19. It is a Phase 3 randomized, controlled trial which is referred to as ACTIV-3, and as a master protocol. This is designed to test several diverse kinds of monoclonal antibody therapies. One of the major benefits of monoclonal antibody therapy is that it can particularly target the SARS-CoV-2 virus and this makes them more potential compared to other drugs.
To Request a Sample of our Report on Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/monoclonal-antibodies-market
Monoclonal Antibodies Market-Segmentation
By Source
- Murine
- Chimeric
- Human
- Humanized
By Application
- Cancer
- Infectious Diseases
- Auto-Immune Diseases
- Inflammatory Diseases
- Others
A full Report of Monoclonal Antibodies Market is Available at: https://www.omrglobal.com/industry-reports/monoclonal-antibodies-market
Monoclonal Antibodies Market– Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca plc
- Aytu BioScience, Inc.
- Bayer AG
- Biocon, Ltd.
- Biogen, Inc.
- Bristol Myers Squibb Co.
- Cadila Pharmaceuticals, Ltd.
- Daiichi Sankyo Company, Ltd.
- Reddy’s Laboratories, Inc.
- Eli Lilly and Co.
- Hoffmann-La Roche AG
- Genmab A/S
- Gilead Sciences, Inc.
- GlaxoSmithKline plc
- Innate Pharma S.A.
- ntas Biopharmaceuticals, Ltd.
- Johnson & Johnson Services, Inc.
- Lupin, Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Novartis AG
- Oncologie, Inc.
- Orchard Therapeutics plc
- Pfizer, Inc.
- Sanofi S.A.
- Spectrum Pharmaceuticals, Inc.
- Sun Pharmaceutical Industries, Ltd.
- Takeda Pharmaceutical Co., Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/monoclonal-antibodies-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
